Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2021 · first_quarter · 1T
Gene therapies, value based payments and drug pricing in general
Value-based Purchasing for Drugs in Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
Source: Senate LDA
Value-based payment and drug pricing in general. S. 2543, Prescription Drug Pricing Reduction Act. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act; value-based payment. Value-based drug pricing and drug pricing in general. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3 Elijah E. Cummings Lower Drug Costs Act.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Elijah E. Cummings Lower Drug Costs Now Act
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act; value-based payment. Value-based drug pricing and drug pricing in general. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3 Elijah E. Cummings Lower Drug Costs Act.
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
Gene therapies, drug pricing, and Bluebird Bio specifically. S. 2543 Prescription Drug Pricing Reduction Act of 2019, Value based payment.
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
Gene therapies, drug pricing, and Bluebird Bio specifically. S. 2543 Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act; value-based payment. Value-based drug pricing and drug pricing in general. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3 Elijah E. Cummings Lower Drug Costs Act.
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
Value-based payment and drug pricing in general. S. 2543, Prescription Drug Pricing Reduction Act. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act: issues related to value-based payment. Issues related to value-based drug pricing and drug pricing in general. Issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act: issues related to value-based payment
Elijah E. Cummings Lower Drug Costs Now Act
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act: issues related to value-based payment. Issues related to value-based drug pricing and drug pricing in general. Issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act: issues related to value-based payment
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act: issues related to value-based payment. Issues related to value-based drug pricing and drug pricing in general. Issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act: issues related to value-based payment
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
Issues related to gene therapies, drug pricing, and Bluebird Bio specifically. Issues related to the S. 2543 Prescription Drug Pricing Reduction Act of 2019
2020 · fourth_quarter · Q4
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Gene therapies, value based payments and drug pricing in general
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB)
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2020 · third_quarter · Q3
Gene therapies, value based payments, and drug pricing in general.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB)
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2020 · second_quarter · Q2
Value-based payment and drug pricing in general. S. 2543, Prescription Drug Pricing Reduction Act. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Gene therapies, drug pricing, and Bluebird Bio specifically. S. 2543 Prescription Drug Pricing Reduction Act of 2019, Value based payment.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2020 · first_quarter · Q1
Gene therapies, drug pricing, and Bluebird Bio specifically. S. 2543 Prescription Drug Pricing Reduction Act of 2019
S. 2543, Prescription Drug Pricing Reduction Act; value-based payment. Value-based drug pricing and drug pricing in general. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3 Elijah E. Cummings Lower Drug Costs Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2019 · fourth_quarter · Q4
Issues related to gene therapies, drug pricing, and Bluebird Bio specifically. Issues related to the S. 2543 Prescription Drug Pricing Reduction Act of 2019
S. 2543, Prescription Drug Pricing Reduction Act: issues related to value-based payment. Issues related to value-based drug pricing and drug pricing in general. Issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act: issues related to value-based payment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE